J&J CEO chides Trump's tariff plan to boost US drugmaking

What does the biopharma industry think of President Donald Trump’s tariff plans? Just ask Joaquin Duato. The Johnson & Johnson CEO subtly but assertively criticized the Trump administration’s plans for pharmaceutical tariffs, saying they are ...

Apr 15, 2025 - 19:54
 0
J&J CEO chides Trump's tariff plan to boost US drugmaking
What does the biopharma industry think of President Donald Trump’s tariff plans? Just ask Joaquin Duato. The Johnson & Johnson CEO subtly but assertively criticized the Trump administration’s plans for pharmaceutical tariffs, saying they are ...